Literature DB >> 12589843

Factors affecting the results of nonsurgical treatment of secretory otitis media in adults.

Eugenijus Lesinskas1.   

Abstract

OBJECTIVE: There is only limited knowledge of the factors influencing the results of nonsurgical treatment of secretory otitis media (SOM) in adults. The present study was carried out to determine the effect of the middle ear (ME) inflation and to clear up the factors affecting the results of conservative treatment of SOM.
METHODS: A total of 198 adult patients were randomized to either a group receiving treatment with ME inflation for 10 days or to a group receiving ME inflation and antibiotics (oral Amoxicillin 500 mg 3/day) for 10 days or to a control group. A wide variety of anamnestic and clinical pre-treatment variables were assessed by administered questionnaires. Pneumo-otoscopy, tympanometry and pure-tone audiometry were performed before the treatment and at the 3-5th, 10th+/-2 and 60th+/-5 day of the study. For the prognostic factors, univariate analyses were first performed to determine the significant predictors, which were afterwards entered into a stepwise logistic regression model.
RESULTS: The effectiveness of treatment was 50.6% in Group A and 58.7% in Group B (control group-11%, P<0.001). The results of treatment were stable and were found unchanged 6 weeks after the treatment. The most important prognostic criteria were defined by analyzing the dynamics of tympanometry (OR, 2.17) and audiometry (OR, 10.27) during conservative treatment. The results of the treatment were related to the mastoid pneumatization, the pathology of paranasal sinuses, the previous history of SOM, the age, and the pre-treatment otoscopic data.
CONCLUSIONS: The results suggest, that daily ME inflation can be effective treatment for adults patients with SOM having regard to the factors significant for the prognosis of treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589843     DOI: 10.1016/s0385-8146(02)00100-1

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  8 in total

1.  Surface area-volume relationships for the mastoid air cell system and tympanum in adult humans: Implications for mastoid function.

Authors:  J Douglas Swarts; Brendan M Cullen Doyle; Cuneyt M Alper; William J Doyle
Journal:  Acta Otolaryngol       Date:  2010-11       Impact factor: 1.494

2.  Role of the mastoid in middle ear pressure regulation.

Authors:  Cuneyt M Alper; Dennis J Kitsko; J Douglas Swarts; Brian Martin; Sancak Yuksel; Brendan M Cullen Doyle; Richard J M Villardo; William J Doyle
Journal:  Laryngoscope       Date:  2011-01-13       Impact factor: 3.325

Review 3.  [Diagnostics of the cochlear amplifier by means of DPOAE growth functions].

Authors:  T Janssen
Journal:  HNO       Date:  2005-02       Impact factor: 1.284

4.  The mastoid as a functional rate-limiter of middle ear pressure change.

Authors:  William J Doyle
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-12-15       Impact factor: 1.675

5.  Relationship between surface area and volume of the mastoid air cell system in adult humans.

Authors:  J D Swarts; B M Cullen Doyle; W J Doyle
Journal:  J Laryngol Otol       Date:  2011-01-05       Impact factor: 1.469

6.  Mastoid geometry in a cross-section of humans from infancy through early adulthood with a confirmed history of otitis media.

Authors:  J Douglas Swarts; Sean Foley; Cuneyt M Alper; William J Doyle
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2011-11-26       Impact factor: 1.675

7.  A cross-sectional study of the change in mastoid geometry with age in children without a history of otitis media.

Authors:  J Douglas Swarts; Sean Foley; Cuneyt M Alper; William J Doyle
Journal:  Laryngoscope       Date:  2012-01-17       Impact factor: 3.325

8.  Normal Mastoid Air Cell System Geometry: Has Surface Area Been Overestimated?

Authors:  Sung Wan Byun; Seung-Sin Lee; Jin Young Park; Jeong Hyun Yoo
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-03-07       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.